Thomas DiRaimondo

Insider Reports History

Location
San Diego, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas DiRaimondo:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Scientific Officer Common Stock 155,825 $2,471,384 $15.86 02 Jan 2026 Direct
Janux Therapeutics, Inc. Chief Scientific Officer Stock option (right to buy) 109,900 02 Jan 2026 Direct

Insider Reports Filed by Thomas DiRaimondo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 02 Jan 2026 3 -$34,394 4 Chief Scientific Officer 02 Jan 2026, 21:00
JANX Janux Therapeutics, Inc. 02 Jan 2025 2 $0 4 Chief Scientific Officer 03 Jan 2025, 20:10
JANX Janux Therapeutics, Inc. 27 Sep 2024 2 -$231,716 4 Chief Scientific Officer 27 Sep 2024, 19:31
JANX Janux Therapeutics, Inc. 02 Jan 2024 1 $0 4 Chief Scientific Officer 03 Jan 2024, 16:47
JANX Janux Therapeutics, Inc. 01 Jan 2024 0 $0 3 Chief Scientific Officer 03 Jan 2024, 16:45